Viewing Study NCT06506292


Ignite Creation Date: 2025-12-24 @ 3:50 PM
Ignite Modification Date: 2026-02-04 @ 3:00 AM
Study NCT ID: NCT06506292
Status: RECRUITING
Last Update Posted: 2024-07-17
First Post: 2024-07-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC)
Sponsor:
Organization: